Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism
| Status: | Recruiting |
|---|---|
| Conditions: | Parkinsons Disease, Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 4/2/2016 |
| Start Date: | July 2013 |
Measurement of Gait Using the Opal APDM and an Instrumented Gait Mat in Persons With Parkinsonism
The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons
living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who
are able to provide informed consent will participate in the assessments.
Outcome variables include selected gait and balance parameters such as cadence, gait-cycle,
stride-length, stride-velocity, turning duration, turning steps, postural sway and
anticipatory postural control. These parameters will be measured by the portable inertial
sensors developed by APDM® and the Zeno/GaitRite.
living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who
are able to provide informed consent will participate in the assessments.
Outcome variables include selected gait and balance parameters such as cadence, gait-cycle,
stride-length, stride-velocity, turning duration, turning steps, postural sway and
anticipatory postural control. These parameters will be measured by the portable inertial
sensors developed by APDM® and the Zeno/GaitRite.
Testing
Participants after screening and consenting will:
1. Have their height measured and fit with the APDM Opals (each device is a two inch
square attached by velcro), one device is attached to each leg, each arm, and the trunk
and chest and receive an introduction to walking on the gait mat.
2. Participants are then asked to walk at a self selected walking speed down the gait mat.
The participants will complete multiple passes (8-10 passes, total 75-100 feet) across
the gait mat while wearing the APDM units to concurrently collect all temporal and
spatial data needed to answer the research question. The Zeno mat is the intended
primary gait mat for this study. The GaitRite will only be utilized in the case of a
technical issue with the Zeno in order to insure completion of the data collection.
Participants after screening and consenting will:
1. Have their height measured and fit with the APDM Opals (each device is a two inch
square attached by velcro), one device is attached to each leg, each arm, and the trunk
and chest and receive an introduction to walking on the gait mat.
2. Participants are then asked to walk at a self selected walking speed down the gait mat.
The participants will complete multiple passes (8-10 passes, total 75-100 feet) across
the gait mat while wearing the APDM units to concurrently collect all temporal and
spatial data needed to answer the research question. The Zeno mat is the intended
primary gait mat for this study. The GaitRite will only be utilized in the case of a
technical issue with the Zeno in order to insure completion of the data collection.
Criteria for Inclusion of Subjects
1. Adults between the ages of 18 and 80 years of age with a primary diagnosis of PD and
similar parkinsonian syndromes
2. Individuals able to walk 100 feet independently, with or without the use of an
assistive device (walker, cane) and follow simple instructions.
3. Individuals with sufficient physiological systemic support to participate in the
study protocol
Criteria for exclusion of Subjects
1. Inability to speak English secondary to the need to understand and follow multistep
directions
2. A secondary diagnosis (musculoskeletal, cardiopulmonary, neurological) that excludes
participation in the study
3. Inability to ambulate 100 feet independently with or without an assistive device.
4. Inability to follow simple instructions necessary for completion of the testing
tasks.
We found this trial at
1
site
U.T. Southwestern Medical Center The story of UT Southwestern Medical Center is one of commitment...
Click here to add this to my saved trials
